A Canadian woman who took part in a landmark study spent nearly a decade handcuffed to her glucose monitor and insulin shots ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin ...

A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...